Published in Blood Weekly, April 29th, 2004
No financial terms or further details of the agreement have been disclosed.
The models will be developed using Ingenium's INGENOtyping technology. As opposed to mouse "knockout" models, the development of genetic rat models remains a scientific hurdle despite years of intense research worldwide, due to the lack of rat embryonic stem cells. Nevertheless, the rat remains the model of choice for many therapeutic areas, including cardiovascular, behavioral,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.